4 resultados para Imi
em Aston University Research Archive
Resumo:
Günümüzde e-perakendeciler tüketicilerin isteklerine cevap verdiklerini iddia ederken, acaba tüketicilere yegane seçenekleri sunmakta olduklarini göz ardi mi ediyorlar? Özellikle gelisen pazar sartlarinda, kamusal alanlarin özellestirilmesi ve güvenlikli sitelerin insasi ile tüketicilerin geo-demografik özellikleri degisirken vakti kisitli ama alim gücü yüksek bireylerin katma degerli farkli hizmet seçenekleri beklentisi içerisine girmelerine yol açiyor. Ancak, günümüzde perakendecilerin yeni e-market uygulamalarina gösterdikleri direnç, modern e-tüketicilerin nitelikli ürün ve servis firsatlarindan faydalanmasini engelliyor. Bilgi ve iletisim teknolojilerindeki son gelismeler, e-kanallar söz konusu oldugunda lojistik aginin küçük ölçekli nitelikli ürünlere yönelik mikro düzeyde degerlendirilmesi gerekmekte ve kentsel yenilenme, e-perakende firmalari, lojistik saglayicilar ve kentsel planlamacilar arasinda bir isbirligi ihtiyaci dogurmaktadir. Ancak öte yandan hizla degisen perakende yapisi içerisinde, yerel cografyanin etkisini ve çoklu iliskileri anlama konusunda e-kanallarda varlik gösteren bu üç oyuncunun gösterdigi karsilikli direnç de önemli bir role sahip olarak ortaya çikmakta. Süreci yöneten üç aktörün dinamik bir pazar yapisi içerisinde e-market dagitim planlama ve uygulama süreçlerine gösterdikleri direnç detayli olarak incelenmelidir. Peki, ucunda daha iyi hizmet verebilmek, daha çok kazanç elde etmek de olsa çoklu entegrasyona ve isbirliksel ortakliga gösterilen bu çift tarafli direncin sebepleri acaba nedir?
Hydrophobicity and surface electrostatic charge of conidia of the mycoparasite Coniothyrium minitans
Resumo:
The effect of increasing culture age on cell surface hydrophobicity (CSH) and cell surface electrostatic charge (measured as zeta potential) of conidia from five isolates of Coniothyrium minitans representing three different morphological types was examined. Conidial CSH of three isolates (A2 960/1, CH1 and CH2) decreased with culture age, whereas CSH of two others (B 1300/2 and IMI 134523) remained high for the whole 42 day experimental period. In contrast, cell surface electrostatic charge decreased uniformly in conidia of all five isolates for the first 34 d and then rose slightly at 42 d. The variation in cell surface electrostatic charge (spectrum width) of the sampled conidia decreased with age for all five isolates. In all five isolates cell surface electrostatic charge of conidia became increasingly negative as the pH of the buffer used to suspend conidia was increased from pH 3.0 to 9.0. No relationship between colony morphology of C. minitans and conidial CSH and cell surface electrostatic charge was found.
Resumo:
Linear Elastic Fracture Mechanics has been used to study the microstructural factors controlling the strength and toughness of two alpha-beta, titanium alloys. Fracture toughness was found to be independent of orientation for alloy Ti/6A1/4-V, but orientation dependent for IMI 700, bend and tension specimens giving similar toughness values. Increasing the solution temperature led to the usual inverse relationship between strength and toughness, with toughness becoming a minimum as the beta transus was approached. The production of a double heat treated microstructure led to a 100% increase in toughness in the high strength alloy and a 20% increase in alloy Ti/6A1/4V, with little decrease in strength. The double heat treated microstruoture was produced by cooling from the beta field into the alpha beta field, followed. by conventional solution treatment and ageing. Forging above the beta transus led to an increase in toughness over alpha beta forging in the high strength alloy, but had little effect on the toughness of Ti/6A1/4V. Light and electron microscopy showed that the increased toughness resulted from the alpha phase being changed from mainly continuous to a discontinuous platelet form in a transformed beta matrix. Void formation occurred at the alpha-beta interface and crack propagation was via the interface or across the platelet depending on which process required the least energy. Varying the solution treatment temperature produced a varying interplatelet spacing and platelet thickness. The finest interplatelet spacing was associated with the highest toughness, since a higher applied stress was required to give the necessary stress concentration to initiate void formation. The thickest alpha platelet size gave the highest toughness which could be interpreted in terms of Krafftt's "process zone size" and the critical crack tip displacement criterion by Hahn and Rosenfield from an analysis by Goodier and Field.
Resumo:
Parkinson's disease is a complex heterogeneous disorder with urgent need for disease-modifying therapies. Progress in successful therapeutic approaches for PD will require an unprecedented level of collaboration. At a workshop hosted by Parkinson's UK and co-organized by Critical Path Institute's (C-Path) Coalition Against Major Diseases (CAMD) Consortiums, investigators from industry, academia, government and regulatory agencies agreed on the need for sharing of data to enable future success. Government agencies included EMA, FDA, NINDS/NIH and IMI (Innovative Medicines Initiative). Emerging discoveries in new biomarkers and genetic endophenotypes are contributing to our understanding of the underlying pathophysiology of PD. In parallel there is growing recognition that early intervention will be key for successful treatments aimed at disease modification. At present, there is a lack of a comprehensive understanding of disease progression and the many factors that contribute to disease progression heterogeneity. Novel therapeutic targets and trial designs that incorporate existing and new biomarkers to evaluate drug effects independently and in combination are required. The integration of robust clinical data sets is viewed as a powerful approach to hasten medical discovery and therapies, as is being realized across diverse disease conditions employing big data analytics for healthcare. The application of lessons learned from parallel efforts is critical to identify barriers and enable a viable path forward. A roadmap is presented for a regulatory, academic, industry and advocacy driven integrated initiative that aims to facilitate and streamline new drug trials and registrations in Parkinson's disease.